Patents by Inventor Ludovic Coutable

Ludovic Coutable has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12133461
    Abstract: A compound of the general formula I wherein R1 is selected from the group consisting of H, alkoxy, alkyl, fluorinated alkyl, partly fluorinated alkyl, and aryl; R4 is selected from the group consisting of H, halogen, CN, alkoxy, alkyl, fluorinated alkyl, partly fluorinated alkyl, branched or linear, cyclic or open-chain alkyl, amino, aryl, and alkenyl; and at least one A1, A2, A3 or A4 in each case is independently the group Ia wherein each variable is as defined herein.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: October 29, 2024
    Assignee: HELIATEK GMBH
    Inventors: Ludovic Coutable, Olga Gerdes, Dirk Hildebrandt, Martin Pfeiffer-Jacob, Nina Grimm
  • Publication number: 20230339982
    Abstract: The invention relates to a compound of the general formula I, to an optoelectronic component containing said type of compound, and to the use of such a compound in an optoelectronic component.
    Type: Application
    Filed: August 31, 2021
    Publication date: October 26, 2023
    Inventors: Rolf ANDERNACH, Ludovic COUTABLE, Roland FITZNER, Krzysztof GUTKOWSKI, Dirk HILDEBRANDT, Kirkus MINDAUGAS, Andre WEISS, Marcus PAPMEYER, Sascha DOROK
  • Publication number: 20220320443
    Abstract: A compound of the general formula I wherein R1 is selected from the group consisting of H, alkoxy, alkyl, fluorinated alkyl, partly fluorinated alkyl, and aryl; R4 is selected from the group consisting of H, halogen, CN, alkoxy, alkyl, fluorinated alkyl, partly fluorinated alkyl, branched or linear, cyclic or open-chain alkyl, amino, aryl, and alkenyl; and at least one A1, A2, A3 or A4 in each case is independently the group Ia wherein each variable is as defined herein.
    Type: Application
    Filed: July 24, 2020
    Publication date: October 6, 2022
    Inventors: Ludovic Coutable, Olga Gerdes, Dirk Hildebrandt, Martin Pfeiffer-Jacob, Nina Schaeffeler
  • Patent number: 10526326
    Abstract: The present invention relates to an adduct of palbociclib, a method of preparing the preparing the same, and a pharmaceutical composition comprising the same. More particularly, the invention provides a crystalline form of palbociclib, a method of preparing the same, as well as a pharmaceutical composition comprising the same.
    Type: Grant
    Filed: July 12, 2016
    Date of Patent: January 7, 2020
    Assignee: ratiopharm GmbH
    Inventors: Jens Geier, Wolfgang Albrecht, Ludovic Coutable, Manfred Erdmann
  • Publication number: 20180222903
    Abstract: The present invention relates to an adduct of palbociclib, a method of preparing the same, as well as a pharmaceutical composition comprising the same.
    Type: Application
    Filed: July 12, 2016
    Publication date: August 9, 2018
    Inventors: Jens GEIER, Wolfgang ALBRECHT, Ludovic COUTABLE, Manfred ERDMANN
  • Patent number: 9856270
    Abstract: Dolutegravir potassium salt and solid state forms thereof are provided, as well as methods of making and interconverting these forms. The Dolutegravir potassium forms, and pharmaceutical compositions containing them, may be used to treat subjects in need of medical treatment, such as for HIV infection.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: January 2, 2018
    Assignee: Ratiopharm GMBH
    Inventors: Wolfgang Albrecht, Ludovic Coutable, Gertraud Koellner
  • Publication number: 20160145269
    Abstract: Dolutegravir potassium salt and solid state forms thereof are provided, as well as methods of making and interconverting these forms. The Dolutegravir potassium forms, and pharmaceutical compositions containing them, may be used to treat subjects in need of medical treatment, such as for HIV infection.
    Type: Application
    Filed: July 17, 2014
    Publication date: May 26, 2016
    Applicant: Ratiopharm GmbH
    Inventors: WOLFGANG ALBRECHT, LUDOVIC COUTABLE, GERTRAUD KOELLNER
  • Patent number: 8329936
    Abstract: The present invention relates to a method for producing cyanoacrylic acid esters. The method is based substantially on a transesterification reaction, wherein the transesterification reaction is performed in the presence of at least one transition metal catalyst that is formed by reacting at least one hydroxyl group-containing support material with at least one transition metal alkoxide.
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: December 11, 2012
    Assignee: Henkel AG & Co. KGaA
    Inventors: Carsten Friese, Andreas Kirschning, Ludovic Coutable
  • Publication number: 20120203021
    Abstract: The present invention relates to a method for producing cyanoacrylic acid esters. The method is based substantially on a transesterification reaction, wherein the transesterification reaction is performed in the presence of at least one transition metal catalyst that is formed by reacting at least one hydroxyl group-containing support material with at least one transition metal alkoxide.
    Type: Application
    Filed: January 3, 2012
    Publication date: August 9, 2012
    Applicant: Henkel AG & Co. KGaa
    Inventors: Carsten Friese, Andreas Kirschning, Ludovic Coutable